1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7 30. 2. Keegan, T.H., et al., Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer, 2016. 122(7): p. 1009 16. 3. Alvarez, E., et al., Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers. Cancer, 2017. 123(13): p. 2516 2523. 4. Hudson, M.M., et al., Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA, 2013. 309(22): p. 2371 2381. 5. Chemaitilly, W., et al., Endocrine late effects in childhood cancer survivors. J Clin Oncol, 2018: p. JCO2017763268. 6. Faubion, S.S., C.L. Loprinzi, and K.J. Ruddy, Management of hormone deprivation symptoms after cancer. Mayo Clin Proc, 2016. 91(8): p. 1133 46. 7. Practice Committees of American Society for Reproductive, M. and T. Society for Assisted Reproductive, Mature oocyte cryopreservation: a guideline. Fertil Steril, 2013. 99(1): p. 37 43.
8. Oktay, K., et al., Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol, 2018. 36(19): p. 1994 2001. 9. Djaladat, H., Organ sparing surgery for testicular tumours. Curr Opin Urol, 2015. 25(2): p. 116 20. 10. Ntali, G. and N. Karavitaki, Efficacy and complications of pituitary irradiation. Endocrinol Metab Clin North Am, 2015. 44(1): p. 117 26. 11. Meistrich, M.L., Effects of chemotherapy and radiotherapy on spermatogenesis in humans, in Fertil Steril. 2013. p. 1180 6. 12. Howell, S.J. and S.M. Shalet, Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr, 2005(34): p. 12 7. 13. Green, D.M., et al., Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol, 2014. 15(11): p. 1215 23. 14. Aldrink, J.H., et al., Using quality improvement methodology to improve ovarian salvage for benign ovarian masses. J Pediatr Surg, 2017. 15. Luczak, J. and M. Baglaj, Selecting treatment method for ovarian masses in children 24 years of experience. J Ovarian Res, 2017. 10(1): p. 59.
16. Gershenson, D.M., Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol, 2017. 41: p. 49 59. 17. Rosendahl, M., M.K. Simonsen, and J.J. Kjer, The influence of unilateral oophorectomy on the age of menopause. Climacteric, 2017: p. 1 5. 18. Bjelland, E.K., et al., Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 Survey). Hum Reprod, 2014. p. 835 841. 19. dizerega, G.S., The peritoneum and its response to surgical injury. Prog Clin Biol Res, 1990. 358: p. 1 11. 20. Practice Committee of the American Society for Reproductive Medicine. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. Fertil Steril, 2007. 88(1): p. 21 6. 21. Meirow, D. and D. Nugent, The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001. 7(6): p. 535 543. 22. Meirow, D., et al., Cortical fibrosis and blood vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007. 22(6): p. 1626 33. 23. Wallace, W.H., et al., Gonadal dysfunction due to cis platinum. Med Pediatr Oncol, 1989. 17(5): p. 409 13.
24. van Dorp, W., et al., Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: A report from the International Late effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. J Clin Oncol, 2016. 34(28): p. 3440 +. 25. Wallace, W.H., et al., Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys, 2005. 62(3): p. 738 44. 26. Larsen, E.C., et al., Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstetricia Et Gynecologica Scandinavica, 2004. 83(1): p. 96 102. 27. Green, D.M., et al., Fertility of female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol, 2009. 27(16): p. 2677 2685. 28. Green, D.M., et al., Quantifying alkylating agent exposure: Evaluation of the cyclophosphamide equivalent dose: A report from the Childhood Cancer Survivor Study. J Clin Oncol, 2011. 29(15). 29. Green, D.M., et al., The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report From the Childhood Cancer Survivor Study. Pediatr Blood Cancer, 2014. 61(1): p. 53 67.
30. Meirow, D., et al., Prevention of severe menorrhagia in oncology patients with treatment induced thrombocytopenia by luteinizing hormonereleasing hormone agonist and depo medroxyprogesterone acetate. Cancer, 2006. 107(7): p. 1634 41. 31. Eifel, P., et al., National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1 3, 2000. J Natl Cancer Inst, 2001. 93(13): p. 979 89. 32. Goldhirsch, A., et al., Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol, 2001. 19(18): p. 3817 27. 33. Turner, N.H., et al., Utility of gonadotropin releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol, 2013. 24(9): p. 2224 35. 34. Del Mastro, L., et al., Gonadotropin releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in cancer women: systematic review and meta analysis of randomized trials. Cancer Treat Rev, 2014. 40(5): p. 675 83.
35. Oktay, K., et al., Absence of conclusive evidence for the safety and efficacy of gonadotropin releasing hormone analogue treatment in protecting against chemotherapy induced gonadal injury. Oncologist, 2007. 12(9): p. 1055 66. 36. Moore, H.C., et al., Goserelin for ovarian protection during breast cancer adjuvant chemotherapy. N Engl J Med, 2015. 372(10): p. 923 32. 37. Hickman, L.C., et al., Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta analysis of the potential role for gonadotropin releasing hormone agonists. J Assist Reprod Genet, 2018. 35(4): p. 571 581. 38. Lambertini, M., et al., Gonadotropin releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta analysis of individual patient level data. J Clin Oncol, 2018. 36(19): p. 1981 1990. 39. Kano, M., et al., AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A, 2017. 114(9): p. E1688 E1697.
40. Woodruff, T.K., A win win for womenʹs reproductive health: A nonsteroidal contraceptive and fertoprotective neoadjuvant. Proc Natl Acad Sci U S A, 2017. 114(9): p. 2101 2102. 41. Gonfloni, S., et al., Inhibition of the c Abl TAp63 pathway protects mouse oocytes from chemotherapy induced death. Nat Med, 2009. 15(10): p. 1179 85. 42. Morgan, S., et al., Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. Plos One, 2013. 8(7). 43. Kerr, J.B., et al., Cisplatin induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib. Nat Med, 2012. 18(8): p. 1170 2; author reply 1172 4. 44. Cherry, S.M., P.A. Hunt, and T.J. Hassold, Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation. Mutat Res GenetToxicol Environ Mutagen, 2004. 564(2): p. 115 128. 45. Woodruff, T.K., Preserving fertility during cancer treatment. Nat Med, 2009. 15(10): p. 1124 5. 46. Wang Rodriguez, J., et al., STI 571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro. Laryngoscope, 2006. 116(8): p. 1409 16. 47. Prockop, D.J., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997. 276(5309): p. 71 4.